[Fund Index | Funds By Family | Fund Top Performers]

Mutual Fund Top Performers - Pacific/Asia ex-Japan Stk

As of 30-Sep-09

Select a symbol for a detailed quote and links to additional information.

Top Performers - 3 Month (out of 169) Fund Name Symbol Return The USX China A HPCHX 39.01% The USX China C HPCCX 38.63% Matthews Korea MAKOX 32.21% DFA Asia Pacific Small Company I DFRSX 28.91% Commonwealth Australia/New Zealand CNZLX 26.04% EM Capital India Gateway I EMIIX 25.55% EM Capital India Gateway A EMINX 25.29% Matthews India MINDX 20.78% Fidelity Advisor Emerging Asia I FERIX 20.69% Fidelity Advisor Emerging Asia A FEAAX 20.61%
Top Performers - 1 Year (out of 146) Fund Name Symbol Return Dreyfus Greater China I DPCRX 76.01% Dreyfus Greater China A DPCAX 75.54% Dreyfus Greater China C DPCCX 74.11% Dreyfus Greater China B DPCBX 74.03% Dreyfus Emerging Asia I DEAIX 68.43% Dreyfus Emerging Asia A DEAAX 68.27% Dreyfus Emerging Asia C DEACX 66.67% Oberweis China Opportunities OBCHX 52.56% Matthews Asia Small Companies MSMLX 41.79% T. Rowe Price New Asia PRASX 41.40%		Top Performers - 3 Year (out of 106) Fund Name Symbol Ann. Ret. Dreyfus Greater China I DPCRX 22.42% Dreyfus Greater China A DPCAX 22.10% Dreyfus Greater China C DPCCX 21.15% AIM China I IACFX 21.14% Dreyfus Greater China B DPCBX 21.09% Matthews China MCHFX 20.99% AIM China Y AMCYX 20.58% AIM China A AACFX 20.48% AIM China B ABCFX 19.60% AIM China C CACFX 19.57%
Top Performers - 5 Year (out of 79) Fund Name Symbol Ann. Ret. Dreyfus Greater China I DPCRX 21.79% Dreyfus Greater China A DPCAX 21.47% Matthews China MCHFX 20.53% Dreyfus Greater China C DPCCX 20.53% Dreyfus Greater China B DPCBX 20.48% Fidelity Advisor Emerging Asia I FERIX 20.41% Fidelity Advisor Emerging Asia A FEAAX 20.10% Fidelity Advisor Emerging Asia T FEATX 19.80% Eaton Vance Greater India A ETGIX 19.51% Fidelity Advisor Emerging Asia C FERCX 19.21%

Get Morningstar's portfolio tools, data, and editorial insights, plus Analyst Reports on 1,450 stocks and 2,000 funds. Start your free 14-day trial today.